Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Viruses
|
July 29, 2023
How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
Emek Kocatürk, Melba Muñoz, Daniel Elieh-Ali-Komi, et al.
Clinical and Translational Allergy
|
October 25, 2023
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
Karoline Krause, Hanna Bonnekoh, Jannis Jelden-Thurm, et al.
Clinical and Translational Allergy
|
August 19, 2015
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
Karsten Weller, Marcus Maurer, Clive Grattan, et al.
Allergy
|
January 9, 2025
CT-P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, Active-Controlled, Phase 3 Study
Sarbjit S Saini, Marcus Maurer, Yevgeniya Dytyatkovska, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 21, 2023
Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment-Results From CURE
Thomas Buttgereit, Carolina Vera, Felix Aulenbacher, et al.
The British Journal of Dermatology
|
April 28, 2025
Characterisation of the clinical and photobiological features of solar urticaria: a United Kingdom multicentre cross-sectional study
Navandeep K Thumber, Hana Elsbahi, Conn McGrath, et al.
Allergy
|
January 14, 2026
Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
Pavel Kolkhir, Pascale Salameh, Magdalena Zajac, et al.
Lancet (London, England)
|
January 11, 2017
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
Olivier Lortholary, Marie Olivia Chandesris, Cristina Bulai Livideanu, et al.
The New England Journal of Medicine
|
October 3, 2019
Ligelizumab for Chronic Spontaneous Urticaria
Marcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Wiener Klinische Wochenschrift
|
November 27, 2012
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Peter Valent, Michel Arock, Patrizia Bonadonna, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Viruses
|
July 29, 2023
How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
Emek Kocatürk, Melba Muñoz, Daniel Elieh-Ali-Komi, et al.
Clinical and Translational Allergy
|
October 25, 2023
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
Karoline Krause, Hanna Bonnekoh, Jannis Jelden-Thurm, et al.
Clinical and Translational Allergy
|
August 19, 2015
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
Karsten Weller, Marcus Maurer, Clive Grattan, et al.
Allergy
|
January 9, 2025
CT-P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, Active-Controlled, Phase 3 Study
Sarbjit S Saini, Marcus Maurer, Yevgeniya Dytyatkovska, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 21, 2023
Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment-Results From CURE
Thomas Buttgereit, Carolina Vera, Felix Aulenbacher, et al.
The British Journal of Dermatology
|
April 28, 2025
Characterisation of the clinical and photobiological features of solar urticaria: a United Kingdom multicentre cross-sectional study
Navandeep K Thumber, Hana Elsbahi, Conn McGrath, et al.
Allergy
|
January 14, 2026
Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
Pavel Kolkhir, Pascale Salameh, Magdalena Zajac, et al.
Lancet (London, England)
|
January 11, 2017
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
Olivier Lortholary, Marie Olivia Chandesris, Cristina Bulai Livideanu, et al.
The New England Journal of Medicine
|
October 3, 2019
Ligelizumab for Chronic Spontaneous Urticaria
Marcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Wiener Klinische Wochenschrift
|
November 27, 2012
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Peter Valent, Michel Arock, Patrizia Bonadonna, et al.
Page
of 6